Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,058,710
  • Shares Outstanding, K 32,811
  • Annual Sales, $ 1,956 M
  • Annual Income, $ 126,830 K
  • 60-Month Beta 0.75
  • Price/Sales 4.15
  • Price/Cash Flow 39.82
  • Price/Book 10.75
Trade AMED with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.45
  • Number of Estimates 8
  • High Estimate 1.49
  • Low Estimate 1.41
  • Prior Year 0.94
  • Growth Rate Est. (year over year) +54.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
230.47 +10.05%
on 11/24/20
273.77 -7.35%
on 11/05/20
-13.27 (-4.97%)
since 11/04/20
3-Month
216.20 +17.31%
on 09/25/20
273.77 -7.35%
on 11/05/20
+22.10 (+9.54%)
since 09/04/20
52-Week
132.95 +90.78%
on 03/17/20
273.77 -7.35%
on 11/05/20
+86.93 (+52.14%)
since 12/04/19

Most Recent Stories

More News
Amedisys (AMED) Down 5.5% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AMED : 253.64 (+3.27%)
Amedisys to Present at the Jefferies Virtual London Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 253.64 (+3.27%)
Amedisys (AMED) Banks on Home Health & Hospice Amid Cost Woe

Amedisys (AMED) continues to benefit from the recent acquisitions of hospice care providers.

AMED : 253.64 (+3.27%)
HOLX : 73.15 (+0.92%)
LH : 198.85 (+1.12%)
ACHC : 42.92 (+2.48%)
Amedisys to Present at the Stephens Annual Investment Conference 2020

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 253.64 (+3.27%)
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

PTH : 149.95 (+1.33%)
AMED : 253.64 (+3.27%)
DHR : 224.43 (+0.49%)
TMO : 474.62 (-0.54%)
XLV : 112.54 (+1.07%)
VHT : 221.09 (+1.29%)
Amedisys to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the...

AMED : 253.64 (+3.27%)
4 Cutting-Edge Healthcare Stocks to Buy for 2021

As COVID brought healthcare stocks back to the spotlight, it will be future healthcare stocks that will bring the largest gains. Here are four that are poised to benefit from an aging population: Seattle...

SGEN : 179.23 (-0.52%)
AMED : 253.64 (+3.27%)
LHCG : 200.88 (+2.67%)
MASI : 265.24 (+1.44%)
3 Reasons Why Amedisys (AMED) Is a Great Growth Stock

Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market.

AMED : 253.64 (+3.27%)
Amedisys (AMED) Beats Q3 Earnings Estimates, Ups 2020 View

An impressive Q3 performance by Amedisys' (AMED) Home health and hospice amid the pandemic-led business disruptions buoys optimism.

AMED : 253.64 (+3.27%)
ALGN : 521.72 (+2.10%)
TMO : 474.62 (-0.54%)
WST : 271.55 (-0.25%)
Amedisys, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 29, 2020 / Amedisys, Inc. (NASDAQ:AMED) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 29, 2020 at 11:00 AM...

AMED : 253.64 (+3.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 260.30
1st Resistance Point 256.97
Last Price 253.64
1st Support Level 247.81
2nd Support Level 241.98

See More

52-Week High 273.77
Last Price 253.64
Fibonacci 61.8% 219.97
Fibonacci 50% 203.36
Fibonacci 38.2% 186.74
52-Week Low 132.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar